Cite
HARVARD Citation
Long, G. et al. (n.d.). Factors predictive of response, disease progression, and overall survival after dabrafenib and trametinib combination treatment: a pooled analysis of individual patient data from randomised trials. Lancet oncology. 17 (12), pp. 1743-1754. [Online].